News

  1. Global CDMO Brings Technological Advancements & Significant Capacity To Ocean County, NJ Location 9/3/2024

    Renaissance Lakewood, LLC (“Renaissance”), a leading pharmaceutical contract development and manufacturing organization (CDMO), today announced the official opening of their new, 67,000 sq ft, expansive warehouse at their recently opened headquarters at 1215 Paco Way in Lakewood, NJ. 

  2. Singota Solutions Announces -40 °C Pallet Storage Offering In EU 8/9/2024

    Singota Solutions, a leading Contract Development and Manufacturing Organization (CDMO), proudly announces the expansion of its service offerings by adding a new -40 °C and -20 °C state-of-the-art pallet storage facility located just outside Milan, Italy.

  3. Shapiro Administration Invests Nearly $3 Million To Bring Adare Pharma Solutions' Headquarters To Pennsylvania, Creating 115 New, Well-Paying Jobs In Philadelphia 8/5/2024

    The life sciences company is investing at least $16.8 million to relocate its headquarters to PA from New Jersey and upgrade its two current Philadelphia facilities, building on Pennsylvania’s reputation as a life sciences leader.

  4. Battelle Prepares To Guide Medical Device Companies Through New Federal, State And International Regulations On "Forever Chemicals" 7/29/2024

    Battelle’s longstanding research, laboratory analysis and consulting expertise in Per- and Polyfluoroalkyl Substances (PFAS) are being applied in a new capacity as the pervasiveness of the chemical class becomes better known and more broadly regulated.

  5. Enable Injections Names New Chief Commercial Officer To Leadership Team 5/30/2024

    As Enable Injections continues to develop and prepare for future commercial success, recent leadership changes and partnership announcements reflect our commitment to commercial growth and supporting our partners with the increasing product demand of enFuse®.

  6. InvestING In Pharmaceutics And Manufacturing Capabilities 4/5/2024
  7. Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession And Board Changes 3/22/2024

    Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that its Board of Directors unanimously approved the conclusion of its review of strategic alternatives that was initiated in March 2023, and, concurrently therewith, announced several strategic updates related to its operations on a stand-alone basis.

  8. SMC Ltd. Announces Expansion Of Sterile Fill Finish Capabilities, Unveiling State-Of-The-Art Facility In North Carolina 3/13/2024

    SMC Ltd., the worldwide contract manufacturer of single use and disposable medical devices, has today announced the acquisition of an end-to-end fill/finish facility in Charlotte, North Carolina. The facility enables SMC to offer a wider portfolio of services to its pharma clients including lab-to-market development, analytical services, device manufacture, fill/finish, final assembly, and secondary packaging.

  9. SGD Pharma Successfully Trials Hydrogen Burners At Its Saint-Quentin-Lamotte (SQLM) Plant To Accelerate Its Ambitious Decarbonization Roadmap 3/12/2024

    At the end of January, SGD Pharma, a global leader in glass primary packaging for the pharmaceutical industry, started a two-week trial using 100% hydrogen burners for industrial-scale glass production. The trial, conducted at SGD Pharma’s state-of-the-art Saint-Quentin-Lamotte (SQLM) manufacturing plant in France, was a resounding success and will inform SGD Pharma’s decarbonization roadmap which aims to reduce CO2 emissions from 2020 by 35% in 2030 and by 65% in 2040.

  10. Bringing Engineering, Clinical Study Expertise To A New Collaboration 3/8/2024

    Battelle, the world’s largest independent, non-profit R&D company, and Spark Biomedical, Inc., a Dallas-based pioneer in wearable neurostimulation technologies are collaborating on the development of a non-invasive device to tackle the harmful effects of Acute Stress Reactions (ASR).